desipramine has been researched along with Delirium in 4 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
| Excerpt | Relevance | Reference |
|---|---|---|
| "An elderly patient treated with low dose Desipramine developed a delirium while her plasma level was in the "subtherapeutic" range." | 7.67 | Desipramine-induced delirium at "subtherapeutic" concentrations: a case report. ( Kutcher, SP; Shulman, KI, 1985) |
| "An elderly patient treated with low dose Desipramine developed a delirium while her plasma level was in the "subtherapeutic" range." | 3.67 | Desipramine-induced delirium at "subtherapeutic" concentrations: a case report. ( Kutcher, SP; Shulman, KI, 1985) |
| "Delirium was documented in 10 cases." | 1.27 | Tricyclic antidepressants and delirium. ( Isenberg, K; Livingston, RL; Wetzel, RD; Zucker, DK, 1983) |
| "Symptomatic orthostatic hypotension, the most common side effect encountered, occurred early in treatment at low desipramine plasma concentrations." | 1.26 | Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics. ( Bock, J; Bowers, MB; Jatlow, PI; Nelson, JC; Quinlan, DM, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahr, H | 1 |
| Battegay, R | 1 |
| Pöldinger, W | 1 |
| Nelson, JC | 1 |
| Jatlow, PI | 1 |
| Bock, J | 1 |
| Quinlan, DM | 1 |
| Bowers, MB | 1 |
| Livingston, RL | 1 |
| Zucker, DK | 1 |
| Isenberg, K | 1 |
| Wetzel, RD | 1 |
| Kutcher, SP | 1 |
| Shulman, KI | 1 |
4 other studies available for desipramine and Delirium
| Article | Year |
|---|---|
[Psychopathological complications in antidepressant medication].
Topics: Amitriptyline; Animals; Antidepressive Agents; Blood Pressure; Delirium; Depression; Desipramine; Do | 1966 |
Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Constipation; Delirium; Depressive Disorder; Desipra | 1982 |
Tricyclic antidepressants and delirium.
Topics: Adolescent; Adult; Age Factors; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Black People; | 1983 |
Desipramine-induced delirium at "subtherapeutic" concentrations: a case report.
Topics: Age Factors; Aged; Delirium; Desipramine; Dose-Response Relationship, Drug; Female; Humans | 1985 |